TULSA, OK – May 3, 2018 – Oklahoma Cancer Specialists and Research Institute (OCSRI) once again received a three-year certification demonstrating our outpatient hematology-oncology services meet and even exceed nationally recognized high standards for quality and safety in cancer care. The certification is through the QOPI® Certification Program (QCP™), an affiliate of the American Society of Clinical Oncology (ASCO®). QCP™ builds on ASCO’s Quality Oncology Practice Initiative (QOPI®).
“The QOPI certification program helps OCSRI asses the quality of care our cancer therapy team provides, specifically within our hematology-oncology services,” said OCSRI CEO, Suanne Gersdorf. “Everyone at OCSRI is dedicated to providing high-quality care to our cancer patients and becoming certified demonstrates our team’s dedication to this mission.”
To receive certification, OCSRI voluntarily participated in a practice-wide evaluation of documentation standards and a comprehensive site assessment against clearly specified standards consistent with national guidelines as well as be successful in meeting the standards and objectives of the QOPI® Certification Program.
The QCP™ seal demonstrates that OCSRI not only scored above the threshold on the key QOPI® quality measures, but also met core chemotherapy safety standards established by ASCO and the Oncology Nursing Society. This includes the following areas of treatment:
- Creating a safe environment—staffing, competencies, and general policy
- Treatment planning, patient consent, and education
- Ordering, preparing, dispensing, and administering chemotherapy
- Monitoring after chemotherapy is administered, including adherence, toxicity, and complications
- Treatment planning
- Staff training and education
- Chemotherapy orders and drug preparation
- Patient consent and education
- Safe chemotherapy administration
- Monitoring and assessment of patient well-being.
“Everyone at OCSRI is dedicated to providing high-quality care to our cancer patients and maintaining certification demonstrates our team’s dedication to this mission,” said Gersdorf.
Oklahoma Cancer Specialists and Research Institute offers the region’s most comprehensive cancer care. We remain active in clinical research trials, strive to implement the latest technologies and provide a continuum of care and support with our patients’ best interests in mind. Above everything, Oklahoma Cancer Specialists and Research Institute is committed to supporting our patients throughout their fights with cancer. We are dedicated to personalized, custom care for each patient.
Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to making a world of difference in cancer care. As the world’s leading organization of its kind, ASCO represents more than 40,000 oncology professionals who care for people living with cancer. Through research, education, and promotion of the highest-quality patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation. Learn more at ASCO.org.
About QOPI Certification Program LLC
QOPI Certification Program LLC is an ASCO affiliate dedicated to recognizing exemplary commitment to safety and quality in oncology patient care. Practices that have achieved QOPI® Certification have scored well on key QOPI® quality measures and have met chemotherapy safety standards established by ASCO and the Oncology Nursing Society in various areas of treatment and chemotherapy safety. For more information, visit: instituteforquality.org.
Chief Administrative Director
Oklahoma Cancer Specialists & Research Institute